Cor Lieftink
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- CRISPR and Genetic Engineering 7
- DNA Repair Mechanisms 5
- Melanoma and MAPK Pathways 5
- Protein Degradation and Inhibitors 5
- RNA Research and Splicing 4
- Epigenetics and DNA Methylation 4
- Oncology 11
- Cancer-related Molecular Pathways 5
- Co-authors
- René Bernards (24 shared papers)Roderick L. Beijersbergen (42 shared papers)Cun Wang (6 shared papers)Bastiaan Evers (5 shared papers)Alberto Bardelli (3 shared papers)Sara Mainardi (4 shared papers)Liqin Wang (7 shared papers)Wenxin Qin (5 shared papers)
- Journals
- Cell Reports (4 papers)Nucleic Acids Research (3 papers)Oncotarget (3 papers)Molecular Cancer Therapeutics (3 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- NetherlandsChinaUnited States
In The Last Decade
Cor Lieftink
47 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 269
- Oncology 437
- Molecular Biology 1.2k
- Immunology 221
- Aging 19
Countries citing papers authored by Cor Lieftink
This map shows the geographic impact of Cor Lieftink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor Lieftink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor Lieftink more than expected).
Fields of papers citing papers by Cor Lieftink
This network shows the impact of papers produced by Cor Lieftink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor Lieftink. The network helps show where Cor Lieftink may publish in the future.
Co-authors
The 25 scholars most cited alongside Cor Lieftink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 231 | |
| 2 | 2017 | 168 | |
| 3 | 2020 | 142 | |
| 4 | 2015 | 113 | |
| 5 | 2014 | 87 | |
| 6 | 2019 | 85 | |
| 7 | 2018 | 79 | |
| 8 | 2018 | 73 | |
| 9 | 2016 | 69 | |
| 10 | 2017 | 64 | |
| 11 | 2016 | 46 | |
| 12 | 2015 | 34 | |
| 13 | 2018 | 34 | |
| 14 | 2016 | 33 | |
| 15 | 2018 | 31 | |
| 16 | 2014 | 31 | |
| 17 | 2016 | 30 | |
| 18 | 2021 | 29 | |
| 19 | 2018 | 28 | |
| 20 | 2017 | 28 |
About Cor Lieftink
Cor Lieftink is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), DNA Repair Mechanisms (5 papers), Cancer Mechanisms and Therapy (5 papers), Melanoma and MAPK Pathways (5 papers), Protein Degradation and Inhibitors (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Research and Splicing (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (269 citations), Oncology (437 citations), Molecular Biology (1.2k citations), Immunology (221 citations) and Aging (19 citations). Cor Lieftink has collaborated with scholars based in Netherlands, China and United States. Frequent co-authors include René Bernards, Roderick L. Beijersbergen, Cun Wang, Bastiaan Evers, Alberto Bardelli, Sara Mainardi, Liqin Wang, Wenxin Qin, Astrid Bosma and Giovanni Germano. Their work appears in journals such as Cell Reports, Nucleic Acids Research, Oncotarget, Molecular Cancer Therapeutics and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.